Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection

British Journal of Nutrition

Volumn 111, Issue 3, 2014, Pages 465-473

  Ouwehand, A C ^a   Ten Bruggencate, S J M ^b   Schonewille, A J ^b   Alhoniemi, E ^c   Forssten, S D ^a   Bovee Oudenhoven, I M J ^b  

^a DUPONT COMPANY   (United States)

^b NIZO FOOD RESEARCH   (Netherlands)

^c Pharmatest Services Ltd   (Finland)

Author keywords

Enterotoxigenic Escherichia coli; Intestinal infection; Lactobacillus acidophilus; Microbiota; Probiotics

Indexed keywords

ABDOMINAL PAIN; ADULT; DIARRHEA; DISEASE RESISTANCE; DOUBLE-BLIND METHOD; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; FECES; FOODBORNE DISEASES; GASTROENTERITIS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LACTOBACILLUS ACIDOPHILUS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; VACCINES, ATTENUATED; YOUNG ADULT;

BACTERIAL ANTIGEN; CALGRANULIN; COLONISATION FACTOR ANTIGEN 2; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LACTOBACILLUS ACIDOPHILUS PROBIOTIC AGENT; LIVE VACCINE; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADAPTIVE IMMUNITY; ADULT; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COUNT; BACTERIUM IDENTIFICATION; BACTEROIDES; BIFIDOBACTERIUM; BLOATING; BRISTOL STOOL SCALE SCORE; CLINICAL ASSESSMENT TOOL; CLOSTRIDIUM; CONTROLLED STUDY; DEFECATION HABIT; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FECES LEVEL; FECES MICROFLORA; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RESISTANCE; INTERVENTION STUDY; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; PREVOTELLA; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

EID: 84893643702     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513002547     Document Type: Article

References (24)

1. Field V, Gautret P, Schlagenhauf P, et al. (2010) Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis 10, 330.
2. Ouwehand AC, Tiihonen K, Saarinen M, et al. (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101, 367-375.
3. Sui J, Leighton S, Busta F, et al. (2002) 16S Ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM. J Appl Microbiol 93, 907-912.
4. Engelbrektson A, Korzenik JR, Pittler A, et al. (2009) Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 58, 663-670.
5. Goldin BR & Gorbach SL (1984) The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39, 756-761.
6. Simenhoff ML, Dunn SR, Zollner GP, et al. (1996) Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 22, 92-96.
7. Paineau D, Carcano D, Leyer G, et al. (2008) Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 53, 107-113.
8. Heiser CR, Ernst JA, Barrett JT, et al. (2004) Probiotics, soluble fiber, and L-glutamine (GLN) reduce nelfinavir (NFV)-or lopinavir/ritonavir (LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care (Chic) 3, 121-129.
9. Bovee-Oudenhoven IM, Lettink-Wissink ML,Van DoesburgW, et al. (2003) Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium. Gastroenterology 125, 469-476.
10. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, et al. (2006) Dietary fructooligosaccharides affect intestinal barrier function in healthy men. J Nutr 136, 70-74.
11. Apajalahti JH, Kettunen H, Kettunen A, et al. (2002) Cultureindependent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Environ Microbiol 68, 4986-4995.
12. Lahtinen SJ, Forssten S, Aakko J, et al. (2012) Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFMw modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age (Dordr) 12, 133-143.
13. Heaton KW, Ghosh S & Braddon FE (1991) How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 32, 73-79.
14. McFarland LV (2007) Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 5, 97-105.
15. Gisbert JP, McNicholl AG & Gomollon F (2009) Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflamm Bowel Dis 15, 1746-1754.
16. Xiang J-Y, Ouyang Q, Li G-D, et al. (2008) Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 14, 53-57.
17. Izcue A, Coombes JL & Powrie F (2009) Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27, 313-338.
18. Ringel-Kulka T, Palsson OS, Maier D, et al. (2011) Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 45, 518-525.
19. Corr SC, Hill C & Gahan CG (2009) Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res 56, 1-15.
20. Ritchie ML & Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLOS ONE 7, e34938.
21. Rinttilä T, Kassinen A, Malinen E, et al. (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97, 1166-1177.
22. Mäkivuokko H, Nurmi J, Nurminen P, et al. (2005) In vitro effects on polydextrose by colonic bacteria and caco-2 cell cyclooxygenase gene expression. Nutr Cancer 52, 94-104.
23. Lahtinen SJ, Forssten S, Aakko J, et al. (2011) Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFMw modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age 34, 133-143.
24. Song Y, Liu C & Finegold SM (2004) Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70, 6459-6465.